Compass Pathways
A publicly traded mental health care company developing psilocybin therapy (COMP360) for treatment-resistant depression and other mental health conditions.
Recently discussed in
What creators say
"Their medicine's likely to be registered as just about as soon as Compass Pathways, another huge pharma company who's an applicant for psilocybin. Over the next six months or so, we anticipate a number of these medicines becoming registered medici..."
More from Tania de Jong →Keep exploring
About this data
- ✓48,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out